Dual-Targeted CAR T-Cell Therapy Displays Early Efficacy in Recurrent Glioblastoma
A CAR T-cell therapy directed toward 2 brain tumor–associated proteins displayed preliminary activity in recurrent glioblastoma.
Source: onclive.com
Donaldm Orourke News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Donaldm Orourke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Donaldm Orourke Today - Breaking & Trending Today
Prescient Therapeutics (ASX:PTX) logs timely progress across anti-cancer programs in Q3
Prescient Therapeutics (ASX:PTX) says it is poised to reach value-adding milestones across its anti-cancer programs after wrapping up the September quarter with a cash balance of $14.8 million.
Source: themarketherald.com.au